0001104659-24-070939.txt : 20240612
0001104659-24-070939.hdr.sgml : 20240612
20240612182305
ACCESSION NUMBER: 0001104659-24-070939
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240611
FILED AS OF DATE: 20240612
DATE AS OF CHANGE: 20240612
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KHOSLA CHAITAN PHD
CENTRAL INDEX KEY: 0001135139
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37853
FILM NUMBER: 241039595
MAIL ADDRESS:
STREET 1: 3832 BAY CENTER PLACE
CITY: HAYWARD
STATE: CA
ZIP: 94545
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Entero Therapeutics, Inc.
CENTRAL INDEX KEY: 0001604191
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 464993860
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 777 YAMATO ROAD
STREET 2: SUITE 502
CITY: BOCA RATON
STATE: FL
ZIP: 33431
BUSINESS PHONE: 561-589-7020
MAIL ADDRESS:
STREET 1: 777 YAMATO ROAD
STREET 2: SUITE 502
CITY: BOCA RATON
STATE: FL
ZIP: 33431
FORMER COMPANY:
FORMER CONFORMED NAME: First Wave BioPharma, Inc.
DATE OF NAME CHANGE: 20210921
FORMER COMPANY:
FORMER CONFORMED NAME: AzurRx BioPharma, Inc.
DATE OF NAME CHANGE: 20141103
FORMER COMPANY:
FORMER CONFORMED NAME: BioPharma d'Azur, Inc.
DATE OF NAME CHANGE: 20140331
4
1
tm2417145-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-06-11
0
0001604191
Entero Therapeutics, Inc.
ENTO
0001135139
KHOSLA CHAITAN PHD
C/O ENTERO THERAPEUTICS, INC
777 YAMATO ROAD, SUITE 502
BOCA RATON
FL
33431
1
0
0
0
0
Common Stock
2024-06-11
4
A
0
24889
0.00
A
24889
D
Common Stock
440
I
See footnote
On June 11, 2024, the Reporting Person was granted 24,889 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units vest in three equal increments on July 1, 2024, September 30, 2024, and December 31, 2024.
Includes unvested RSUs.
Held directly by the Chaitan Khosla Living Trust, in which the Reporting Person serves as the sole Trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
/s/ Sarah Romano, Attorney-in-Fact for Chaitan Khosla
2024-06-12